Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca makes regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer in Japan
-
AstraZeneca and Chinese Future Industry Investment Fund establish joint venture to develop new medicines in China
-
Faslodex receives US FDA approval for the treatment of advanced breast cancer in combination with abemaciclib
-
Fasenra (benralizumab) receives US FDA approval for severe eosinophilic asthma
-
Benralizumab receives positive EU CHMP opinion for severe, uncontrolled eosinophilic asthma
-
Year-To-Date and Q3 2017 Results
-
AstraZeneca shares scientific updates from its extensive cardiovascular, renal and metabolic diseases (CVMD) portfolio at AHA 2017
-
AstraZeneca provides update on tralokinumab Phase III programme in severe, uncontrolled asthma
-
US FDA approves AstraZeneca’s Calquence (acalabrutinib) for adult patients with previously-treated mantle cell lymphoma
-
AstraZeneca and Incyte enter clinical trial collaboration in early lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
